Top Markets
Coin of the day
GeneFerm Biotechnology Co., Ltd. GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd.

1796
Rang in Aktien #26679
GeneFerm Biotechnology Co., Ltd. specializes in the development, production,... GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
Aktienkurs
$0.93330147
Marktkapitalisierung
$38.69M
Veränderung (1 Tag)
-1.01%
Veränderung (1 Jahr)
-39.84%
Land
TW
Handel GeneFerm Biotechnology Co., Ltd. (1796)

Kategorie

P/S-Verhältnis für GeneFerm Biotechnology Co., Ltd. (1796)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von GeneFerm Biotechnology Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für GeneFerm Biotechnology Co., Ltd. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber